InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by DESOUZA ERROL B, Director. Director active across 2 companies, notably Royalty Pharma plc. In total, 7 reports have been logged. History available since 25 June 2021. The latest transaction was disclosed on 24 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
6,328 shares0Class A Ordinary SharesSEC:0000899243-22-024038:0
3,588 shares0Common StockSEC:0001209191-21-059424
3,588 shares0Common StockSEC:0001209191-21-059424:0
3,406 shares0Common StockSEC:0001209191-21-044688:0
3,406 shares0Common StockSEC:0001209191-21-044688
5,726 shares0Class A Ordinary SharesSEC:0000950103-21-009693:0
5,726 shares0Class A Ordinary SharesSEC:0000950103-21-009693
7 of 7 declarations
About DESOUZA ERROL B
Errol B. Desouza is a Board Member at Royalty Pharma plc and Catalyst Biosciences, Inc. He brings valuable expertise in corporate governance and strategy. His role involves overseeing operations and ensuring that decisions made align with the long-term goals of the companies. His commitment to operational excellence is an asset to Royalty Pharma and Catalyst Biosciences.
